Technological advancements, changing cultural expectations around data diversity, and “The Great Resignation” have all hit the life sciences industry at the same time as a global pandemic.
Read More
Often, the patient experience comes down to whom they interact with at the clinic. Patients need a care team who understands their community. Through a culturally sensitive patient experience,...
Read More
As the spring conference season comes to an end, we’re reflecting on what we learned and identifying practical ways we can support clinical researchers, healthcare providers, and patients. Because...
Read More
For decades, researchers and government agencies have had their eyes on diversity in clinical trials. On April 13, The U.S. Food and Drug Administration issued a draft guidance recommending that...
Read More
At 20/20 Onsite, we pride ourselves on providing excellent customer service and a great patient experience. As Clinical Trial Manager, Pamela Tomic plays a pivotal role in our team’s ability to build...
Read More
The time it takes to complete clinical trials has been steadily rising for over a decade, as treatments and their regulations become more complex. By reducing the time it takes to complete clinical...
Read More
A recent study by WCG highlighted some of the top post-pandemic clinical trial enrollment challenges sites and sponsors are facing in 2022. Not surprisingly, COVID-19 has completely altered the way...
Read More
The average cost of a phase 1 clinical trial is $4 million. At this early stage of drug development, patient recruitment delays can quickly drain a clinical trial budget. To keep timelines on track,...
Read More